News

A recent, popular Talking Point presentation by Dr Haley Peckham offers a complementary way of understanding the brain’s response to growing up in a harsh environment.

Congratulations to Dr Rowan Ogeil, who has just been appointed to the Editorial Board of Drug and Alcohol Review as a Deputy Editor.

Turning Point and MARC have made a joint submission to the Victorian consultation on the implementation of carded play and pre-commitment on poker machines across the state.

Health4hHer is an evidence-based health promotion program that helps women attending breast screening services protect themselves from the harm caused by alcohol.

Better regulation and community education are needed to manage the risks associated with zero-alcohol drinks. 

PhD Scholarships at $33,000 per annum are now available. We also welcome students across different levels and backgrounds, from Honours, Master’s and PhD students, to medical practitioners and clinicians undertaking research projects.

The prestigious Young Tall Poppy Science Awards are run by the Australian Institute of Policy and Science (AIPS) to honour up-and-coming scientists who combine world-class research with a passionate commitment to communicating science.

The latest AODstats Bulletin has just been released with a focus on drug-related hospital admissions in the years 2020–21 and 2021–22.

A new paper has found that the BreakThrough peer-led group is an effective support for a family member who has a loved one experiencing addiction.

A new article by Monash Addiction Research Centre’s Deputy Director, Professor Suzanne Nielsen and Turning Point's Executive Clinical Director, Professor Dan Lubman AM, has been published in the Monash Lens, calling on Australia to act now to get ahead of the fentanyl threat.

The importance of drawing on up-to-date evidence to monitor the impact of policy change on prescribing practices has recently been highlighted in the findings from a team of researchers at Monash Addiction Research Centre.

An article published this month in the Medical Journal of Australia by Turning Point’s addiction trainee registrar, Dr Richard Bradlow, has identified a risk that dihydrocodeine misuse may be missed in clinical practice due to a lack of knowledge.